The expression of significantly hypermethylated (DISP2, MARK3, TDRD6, TRIP10, and ZNF197) or hypomethylated (ACP5, ARL8A, C1orf54, HDAC9, RAB31, and UGT3A2) sets of genes in the livers of patients with NASH was examined individually via real-time quantitative PCR (Figure S11d). This evidence concerns the gene RAB31 and metabolic dysfunction-associated steatohepatitis.